RevSpring to Acquire Kyruus Health, Creating a Connected Care Journey from Search to Final Payment Unified platform will support whole-person engagement while simplifying operations and improving financial outcomes for healthcare organizations NASHVILLE, Tenn., and...
Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies – New open label data in Becker demonstrated sustained disease stabilization up to three years, reinforcing prior clinical findings – – Ongoing pivotal...
Kyruus Health and Healthgrades Partner to Improve Patient Access and Digital Presence for Healthcare Providers BOSTON, Mass., Oct. 1, 2025 — Kyruus Health, the leading care access platform, today announced a strategic partnership with Healthgrades, the premier...
Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer Proceeds will fund a global pivotal trial of lead product candidate, ELA026, as a frontline treatment for secondary...
STAR THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $125 MILLION SERIES D FINANCING Proceeds to support continued clinical advancement of lead program, VGA039, a first-in-class antibody targeting protein S for the treatment of bleeding disorders, starting with von Willebrand...
Recent Comments